this invention relates to the administration of novel substituted tryptamines and related derivatives for the treatment of several types of medical conditions , such as prostate conditions , impotence , cardiovascula disorders , central nervous system and psychiatric disorders , chronobiological - based disorders , endocrine indications , neoplastic conditions , conditions associated with senescence , ophthalmological diseases , cluster headaches and migraines , and weight gain disorders .